Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2013

Dec 6, 2013

30786_dirs_2013-12-06_d0ca94a3-181f-49cb-8799-7c433a3e6a76.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO RAD LABORATORIES INC (BIO, BIO.B)
CIK: 0000012208
Period of Report: 2013-12-05

Reporting Person: GOETZ JOHN (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-12-05 Bio-Rad A Common Stock M 8000 $53.75 Acquired 52396.9995 Direct
2013-12-05 Bio-Rad A Common Stock F 5220 $121.58 Disposed 47176.9995 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-12-05 Non-Qualified Stock Option (right to buy) $53.75 M 8000 Disposed 2014-02-04 Bio-Rad A Common Stock (8000) Direct

Footnotes

F1: The option vested in five equal annual installments beginning on February 4, 2005.